Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2692)
All Articles published online
|
Sep 14, 2006 (publication date) through May 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chavalitdhamrong D, Tanwandee T. Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment. World J Gastroenterol 2006; 12(34): 5532-5535 [PMID: 17006994 DOI: 10.3748/wjg.v12.i34.5532] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i34/5532.htm |
| Number | Citing Articles |
| 1 |
Alfredo Alberti. Impact of a sustained virological response on the long‐term outcome of hepatitis C. Liver International 2011; 31(s1): 18 doi: 10.1111/j.1478-3231.2010.02378.x
|
| 2 |
Ronald L Koretz, Maria Pleguezuelo, Vasiliki Arvaniti, Pilar Barrera Baena, Ruben Ciria, Kurinchi Selvan Gurusamy, Brian R Davidson, Andrew K Burroughs. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C. Cochrane Database of Systematic Reviews 2013; doi: 10.1002/14651858.CD003617.pub2
|
| 3 |
Vasilios Papastergiou, Maria Stampori, Phillipos Lisgos, Crisostomos Pselas, Kleopatra Prodromidou, Stylianos Karatapanis. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C. European Journal of Gastroenterology & Hepatology 2013; 25(7): 798 doi: 10.1097/MEG.0b013e32835eb8bf
|
| 4 |
Jun Hanaoka, Mitsuo Shimada, Toru Ikegami, Satoru Imura, Yuji Morine, Hirofumi Kanemura, Yusuke Arakawa. A case of surgical treatment for hepatocellular carcinoma that developed in a chronic hepatitis C patient who had shown sustained virological response to interferon 11 years before. Kanzo 2008; 49(6): 248 doi: 10.2957/kanzo.49.248
|
| 5 |
Sandro da Costa Ferreira, Marcos de Vasconcelos Carneiro, Fernanda Fernandes Souza, Andreza Corrêa Teixeira, Marcia Guimarães Villanova, José Fernando de Castro Figueiredo, Afonso Dinis Costa Passos, Leandra Naira Zambelli Ramalho, Sergio Zucoloto, Ana de Lourdes Candolo Martinelli. Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon. The Brazilian Journal of Infectious Diseases 2010; 14(4): 330 doi: 10.1016/S1413-8670(10)70070-2
|
| 6 |
X. Wang, F. Gao, G. Yuan, K. Shi, Y. Huang, Y. Chen, R. Qiu, L. Sun, J. Liu, C. Hu, Y. Zhou. Ten‐year follow‐up analysis of chronic hepatitis C patients after getting sustained virological response to pegylated interferon‐α and ribavirin therapy. Journal of Viral Hepatitis 2016; 23(12): 971 doi: 10.1111/jvh.12574
|
| 7 |
Anca Trifan, Ermina Stratina, Adrian Rotaru, Remus Stafie, Sebastian Zenovia, Robert Nastasa, Laura Huiban, Catalin Sfarti, Camelia Cojocariu, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Carol Stanciu. Changes in Liver Steatosis Using Controlled Attenuation Parameter among Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals Therapy Who Achieved Sustained Virological Response. Diagnostics 2022; 12(3): 702 doi: 10.3390/diagnostics12030702
|
| 8 |
Coralie Hermetet, Frederic Dubois, Catherine Gaudy-Graffin, Yannick Bacq, Bernard Royer, Christophe Gaborit, Louis D’Alteroche, Jean Claude Desenclos, Philippe Roingeard, Leslie Grammatico-Guillon, Yury E. Khudyakov. Continuum of hepatitis C care in France: A 20-year cohort study. PLOS ONE 2017; 12(8): e0183232 doi: 10.1371/journal.pone.0183232
|
| 9 |
Justin L. Sewell, Kristine M. Stick, Alexander Monto. Hepatocellular carcinoma after sustained virologic response in hepatitis C patients without cirrhosis on a pretreatment liver biopsy. European Journal of Gastroenterology & Hepatology 2009; 21(2): 225 doi: 10.1097/MEG.0b013e32831101b7
|
| 10 |
Sang Bun Choi, Youn Jae Lee, Jae Ik Lee, Young Jin Song, Byoung Jin Choi, Jong Han Kim, Eun Uk Jung, Sung Jae Park, Sang Heon Lee, Ji Hyun Kim, Jung Sik Choi, Sam Ryong Jee, Sang Yong Seol. Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin. The Korean Journal of Hepatology 2011; 17(3): 183 doi: 10.3350/kjhep.2011.17.3.183
|
| 11 |
AJIT PRATAP SINGH, PANKAJ ASATI, KANISHK YADAV. CLINICAL PROFILE AND TREATMENT RESPONSE TO SOFOSBUVIR-VELPATASVIR REGIMEN AND ITS IMPACT ON THE QUALITY OF LIFE IN CHRONIC HEPATITIS C PATIENTS. International Journal of Pharmacy and Pharmaceutical Sciences 2023; : 10 doi: 10.22159/ijpps.2023v15i9.48349
|
| 12 |
Bryony Simmons, Jawaad Saleem, Andrew Hill, Richard D. Riley, Graham S. Cooke. Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis. Clinical Infectious Diseases 2016; 62(6): 683 doi: 10.1093/cid/civ948
|
| 13 |
B. L. Pearlman, N. Traub. Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More. Clinical Infectious Diseases 2011; 52(7): 889 doi: 10.1093/cid/cir076
|
| 14 |
Marcello Persico, Savino Bruno, Andrea Costantino, Marta Mazza, Piero Luigi Almasio. The Impact of Antiviral Therapy and the Influence of Metabolic Cofactors on the Outcome of Chronic HCV Infection. International Journal of Hepatology 2011; 2011: 1 doi: 10.4061/2011/314301
|
| 15 |
David R. Nelson, Gary L. Davis, Ira Jacobson, Gregory T. Everson, Michael W. Fried, Stephen A. Harrison, Tarek Hassanein, Donald M. Jensen, Karen L. Lindsay, Norah Terrault, Nizar Zein. Hepatitis C Virus: A Critical Appraisal of Approaches to Therapy. Clinical Gastroenterology and Hepatology 2009; 7(4): 397 doi: 10.1016/j.cgh.2008.11.016
|
| 16 |
Charlotte Lybeck, Erwin D. Brenndörfer, Matti Sällberg, Scott M. Montgomery, Soo Aleman, Ann-Sofi Duberg. Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients. European Journal of Gastroenterology & Hepatology 2019; 31(4): 506 doi: 10.1097/MEG.0000000000001316
|
| 17 |
Y. Kitay-Cohen, L. Goldberg-Bittman, R. Hadary, M.D. Fejgin, A. Amiel. Telomere length in Hepatitis C. Cancer Genetics and Cytogenetics 2008; 187(1): 34 doi: 10.1016/j.cancergencyto.2008.08.006
|
| 18 |
Amiel A., Fejgin M. D., Goldberg-Bittman L., Sharoni R., Hadary R., Kitay-Cohen Y.. Telomere Aggregates in Hepatitis C Patients. Cancer Investigation 2009; 27(6): 650 doi: 10.1080/07357900802350806
|
| 19 |
K. Rutter, A. F. Stättermayer, S. Beinhardt, T.-M. Scherzer, P. Steindl-Munda, M. Trauner, P. Ferenci, H. Hofer. Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C. Alimentary Pharmacology & Therapeutics 2015; 41(6): 521 doi: 10.1111/apt.13085
|
| 20 |
Martin-Walter Welker, Stefan Zeuzem. Occult hepatitis C: How convincing are the current data?. Hepatology 2009; 49(2): 665 doi: 10.1002/hep.22706
|
| 21 |
Mark G. Swain, Ming–Yang Lai, Mitchell L. Shiffman, W. Graham E. Cooksley, Stefan Zeuzem, Douglas T. Dieterich, Armand Abergel, Mário G. Pessôa, Amy Lin, Andreas Tietz, Edward V. Connell, Moisés Diago. A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin. Gastroenterology 2010; 139(5): 1593 doi: 10.1053/j.gastro.2010.07.009
|
| 22 |
Kensaku Sanefuji, Hiroto Kayashima, Tomohiro Iguchi, Keishi Sugimachi, Yo‐ichi Yamashita, Tomoharu Yoshizumi, Yuji Soejima, Takashi Nishizaki, Akinobu Taketomi, Yoshihiko Maehara. Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C. Journal of Surgical Oncology 2009; 99(1): 32 doi: 10.1002/jso.21176
|
| 23 |
Lilach Goldberg-Bittman, Aliza Amiel, Ruth Hadary, Moshe D. Fejgin, Miriam Quitt, Yona Kitay-Cohen. Telomere capture in hepatitis C infection. Cancer Genetics and Cytogenetics 2009; 191(2): 63 doi: 10.1016/j.cancergencyto.2009.01.013
|
| 24 |
Christian Gluud, Jesper Brok, Yan Gong, Ronald L. Koretz. Hepatology may have problems with putative surrogate outcome measures. Journal of Hepatology 2007; 46(4): 734 doi: 10.1016/j.jhep.2007.01.003
|